263 related articles for article (PubMed ID: 17895529)
1. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
[TBL] [Abstract][Full Text] [Related]
2. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
3. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
[TBL] [Abstract][Full Text] [Related]
4. Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Yoshikawa E; Nishina T; Miyazaki M; Ikeda T; Komeda M
Eur J Cardiothorac Surg; 2008 Jan; 33(1):25-31. PubMed ID: 18054245
[TBL] [Abstract][Full Text] [Related]
5. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Eur J Pharmacol; 2008 Feb; 581(1-2):121-31. PubMed ID: 18154949
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
[TBL] [Abstract][Full Text] [Related]
8. Attenuating effects of chymase inhibitor on pericardial adhesion following cardiac surgery.
Soga Y; Takai S; Koyama T; Okamoto Y; Ikeda T; Nishimura K; Miyazaki M; Komeda M
J Card Surg; 2007; 22(4):343-7. PubMed ID: 17661781
[TBL] [Abstract][Full Text] [Related]
9. Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.
Liu W; Chen J; Xu T; Tian W; Li Y; Zhang Z; Li W
Am J Hypertens; 2012 Feb; 25(2):250-60. PubMed ID: 22089109
[TBL] [Abstract][Full Text] [Related]
10. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M
J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA therapy against carbohydrate sulfotransferase 15 inhibits cardiac remodeling in rats with dilated cardiomyopathy.
Watanabe K; Arumugam S; Sreedhar R; Thandavarayan RA; Nakamura T; Nakamura M; Harima M; Yoneyama H; Suzuki K
Cell Signal; 2015 Jul; 27(7):1517-24. PubMed ID: 25778904
[TBL] [Abstract][Full Text] [Related]
14. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
Miyazaki M; Takai S; Jin D; Muramatsu M
Pharmacol Ther; 2006 Dec; 112(3):668-76. PubMed ID: 16837049
[TBL] [Abstract][Full Text] [Related]
15. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
[TBL] [Abstract][Full Text] [Related]
16. An antiarrhythmic effect of a chymase inhibitor after myocardial infarction.
Jin D; Takai S; Sakaguchi M; Okamoto Y; Muramatsu M; Miyazaki M
J Pharmacol Exp Ther; 2004 May; 309(2):490-7. PubMed ID: 14730006
[TBL] [Abstract][Full Text] [Related]
17. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
Juan W; Nakazawa M; Watanabe K; Ma M; Wahed MI; Hasegawa G; Naito M; Yamamoto T; Fuse K; Kato K; Kodama M; Aizawa Y
Mol Cell Biochem; 2003 Sep; 251(1-2):77-82. PubMed ID: 14575307
[TBL] [Abstract][Full Text] [Related]
18. Long-term carperitide treatment attenuates left ventricular remodeling in rats with heart failure after autoimmune myocarditis.
Tanaka K; Ito M; Kodama M; Hoyano M; Kimura S; Mitsuma W; Hirono S; Adachi T; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2009 Sep; 54(3):232-9. PubMed ID: 19668089
[TBL] [Abstract][Full Text] [Related]
19. Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosis.
Arumugam S; Mito S; Thandavarayan RA; Giridharan VV; Pitchaimani V; Karuppagounder V; Harima M; Nomoto M; Suzuki K; Watanabe K
Cardiovasc Ther; 2013 Dec; 31(6):352-62. PubMed ID: 23480557
[TBL] [Abstract][Full Text] [Related]
20. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
Prosser HC; Forster ME; Richards AM; Pemberton CJ
Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
